Literature DB >> 19337976

Melatonin modulates microfilament phenotypes in epithelial cells: implications for adhesion and inhibition of cancer cell migration.

G Benítez-King1, E Soto-Vega, G Ramírez-Rodriguez.   

Abstract

Cell migration and adhesion are cytoskeleton- dependent functions that play a key role in epithelial physiology. Specialized epithelial cells in water transport have specific microfilament rearrangements that make these cells adopt a polyhedral shape, forming a sealed monolayer which functions as permeability barrier. Also, specific polarized microfilament phenotypes are formed at the front and the rear of migratory epithelial cells. In pathological processes such as cancer, increased migration occurs in invasive cells driven by the formation of polarized and differential microfilament phenotypes. Melatonin, the main product secreted by the pineal gland during dark phase of the photoperiod, acts as a cytoskeletal modulator in normal and cancer cells. In this paper we will summarize evidence supporting that melatonin acts as a microfilament modulator in epithelial MDCK cells, and we will describe its effects on cytoskeleton organization involved in the mechanism by which melatonin synchronizes water transport. In addition, we will review recent data that indicate that melatonin is able to switch microfilament phenotypes in MCF-7 human mammary cancer cells, from invasive migratory cells to dormant microfilament phenotypes that occur in non- migratory cells. Moreover, we will discuss the implications of the cytoskeleton as therapeutic target for cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19337976     DOI: 10.14670/HH-24.789

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  15 in total

Review 1.  Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Authors:  Sara Proietti; Alessandra Cucina; Russel J Reiter; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

Review 2.  Melatonin, an ubiquitous metabolic regulator: functions, mechanisms and effects on circadian disruption and degenerative diseases.

Authors:  Andreea Iulia Socaciu; Răzvan Ionuţ; Mihai Adrian Socaciu; Andreea Petra Ungur; Maria Bârsan; Angelica Chiorean; Carmen Socaciu; Armand Gabriel Râjnoveanu
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

Review 3.  Peripheral reproductive organ health and melatonin: ready for prime time.

Authors:  Russel J Reiter; Sergio A Rosales-Corral; Lucien C Manchester; Dun-Xian Tan
Journal:  Int J Mol Sci       Date:  2013-04-02       Impact factor: 5.923

4.  A Comparison of B16 Melanoma Cells and 3T3 Fibroblasts Concerning Cell Viability and ROS Production in the Presence of Melatonin, Tested Over a Wide Range of Concentrations.

Authors:  Maria Angeles Bonmati-Carrion; Nuria Alvarez-Sánchez; Rüdiger Hardeland; Juan Antonio Madrid; Maria Angeles Rol
Journal:  Int J Mol Sci       Date:  2013-02-14       Impact factor: 5.923

5.  Actin Disorganization Plays a Vital Role in Impaired Embryonic Development of In Vitro-Produced Mouse Preimplantation Embryos.

Authors:  Kun Tan; Lei An; Shu-Min Wang; Xiao-Dong Wang; Zhen-Ni Zhang; Kai Miao; Lin-Lin Sui; Shu-Zhi He; Jing-Zhou Nie; Zhong-Hong Wu; Jian-Hui Tian
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

6.  Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinoma.

Authors:  Lizhu Jiang; Peng Wang; Hongyan Chen
Journal:  Ups J Med Sci       Date:  2014-09-18       Impact factor: 2.384

7.  Fascin-1, ezrin and paxillin contribute to the malignant progression and are predictors of clinical prognosis in laryngeal squamous cell carcinoma.

Authors:  Wei Gao; Chunming Zhang; Yan Feng; Ganggang Chen; Shuxin Wen; Hui Huangfu; Binquan Wang
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

8.  Action of melatonin on squamous cell carcinoma and other tumors of the oral cavity (Review).

Authors:  Antonio Cutando; Antonio López-Valverde; Joaquin DE Vicente; Julian López Gimenez; Isaac Alias Carcía; Rafael Gomez DE Diego
Journal:  Oncol Lett       Date:  2014-01-20       Impact factor: 2.967

9.  Melatonin inhibits the migration of human lung adenocarcinoma A549 cell lines involving JNK/MAPK pathway.

Authors:  Qiaoyun Zhou; Shuyu Gui; Qing Zhou; Yuan Wang
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

10.  Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action.

Authors:  Pawel P Posadzki; Ram Bajpai; Bhone Myint Kyaw; Nicola J Roberts; Amnon Brzezinski; George I Christopoulos; Ushashree Divakar; Shweta Bajpai; Michael Soljak; Gerard Dunleavy; Krister Jarbrink; Ei Ei Khaing Nang; Chee Kiong Soh; Josip Car
Journal:  BMC Med       Date:  2018-02-05       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.